Some Issues Relevant to Establishing a Universal Newborn Hearing Screening Program

Abstract

This article describes some of the factors relevant to the establishment of a universal newborn hearing screening (UNHS) program. First, the difficulty in providing precise estimates of test sensitivity and specificity are reviewed. This section is followed by hypothetical estimates of overall programmatic costs, first for a fixed number of babies to be screened and then as a function of the number of babies to be screened in a year. Included in these estimates are the costs for equipment, disposables, personnel, and follow-up testing. These estimates are provided for three different screening protocols: auditory brainstem response (ABR) alone, otoacoustic emission (OAE) alone, and OAE followed by ABR only for those babies who failed the OAE screening. If follow-up costs are not included, it is less expensive to screen newborns with OAEs compared with the other two protocols. However, once follow-up testing is included as part of the program costs and there are at least 400 births per year, procedures in which OAEs are performed first, followed by an ABR on those infants who do not pass the OAE test, result in the lowest costs. Hospitals with as few as 400 births per year should expect per-baby costs not exceeding $30, regardless of which protocol is used. For all three protocols, the unit costs decrease as the number of babies screened increases. The final section describes data from a local UNHS program in which all infants are screened first with an OAE test, followed by an ABR test on infants not passing the OAE screening. Idiosyncratic features to this program are described, including the fact that all screening tests are performed by audiologists, who are paid on a part-time basis, adding cost to the program. Even under these circumstances, the unit cost is under $30. These data lead us to conclude that all infants can be screened in a cost-effective manner.

Abbreviations: ABR = auditory brainstem response, DPOAE = distortion product otoacoustic emission, NICU = neonatal intensive care unit, OAE = otoacoustic emission, UNHS = universal newborn hearing screening

Keywords

Follow-up costs - program costs - universal newborn hearing screening

• REFERENCES

• Chang KW, Vohr BR, Norton SJ, Lekas MD. (1993).External and middle ear status related to evoked otoacoustic emission in neonates. Arch Otolaryngol Head Neck Surg 119:276–283.
• Gorga MP, Neely ST, Dorn PA. (1999). DPOAE test performance for a priori criteria and for multifrequency audiometric standards. Ear Hear 20:345–362.
• Gravel J, Berg A, Bradley M, Cacace A, Campbell D, Dalzell L, DeCristofaro J, Greenberg E, Gross S, Orlando M, Pinheiro J, Regan J, Spivak L, Stevens R, Prieve B. (2000). New York State Universal Newborn Hearing Screening Demonstration Project: effects of screening protocol on inpatient outcome measures. Ear Hear 21:131–140.
• Harrison M, Roush J. (1996). Age of suspicion, identification, and intervention for infants and young children with hearing loss: a national study. Ear Hear 17:55–62.
• Johnson JL, Mauk GW Takekawa KM, Simon PR, Sia CCJ, Blackwell PM. (1993). Implementing a statewide system of services for infants and toddlers with hearing disabilities. Semin Hear 14:105–119.
• Kanne TJ, Schaefer L, Perkins JA. (1999). Potential pitfalls of initiating a newborn hearing screening program. Arch Otolaryngol Head Neck Surg 125:28–32.
• KemperAR, Downs SM. (2000). A cost-effectiveness analysis of newborn hearing screening strategies. Arch Pediatr Adolesc Med 154:484–488.
• Kok MR, van Zanten GA, Brocaar MP. (1992). Growth of evoked otoacoustic emissions during the first days postpartum. A preliminary report. Audiology 31:140–149.
• Maxon AB, White KR, Behrens TR, Vohr BR. (1995). Referral rates and cost efficiency in a universal newborn hearing screening program using transient evoked otoacoustic emissions (TEOAE). J Am Acad Audiol 6:271–277.
• Mehl AL, Thomson V (1998). Newborn hearing screening: the great omission. Pediatrics 101:1–6.
• National Institutes of Health. (1993). Early identification of hearing impairment in infants and young children. NIH Consens Statement 1–24.
• Norton SJ, Gorga MP, Widen JE, Folsom RC, Sininger Y, Cone-Wesson B, Vohr BR, Mascher K, Fletcher KA. (2000). Identification of neonatal hearing impairment: evaluation of TEOAE, DPOAE, and ABR test performance. Ear Hear 21:508–528.
• Robinette MS, White KR. (1998). The state of newborn hearing screening. In: Bess FH, ed. Children with Hearing Impairment: Contemporary trends. Nashville, TN: Vanderbilt Bill Wilkerson Center Press, 45–67.